Affinity Asset Advisors »

Engene Holdings shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $526k 77k 6.83
2025-06-30 $280k 77k 3.64

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
VR Adviser
Kynam Capital Management
Blue Owl Capital Holdings
Cormorant Asset Management
Braidwell
Deep Track Capital
Perceptive Advisors
Point72 Asset Management
Frazier Life Sciences Management
Franklin Resources
Adage Capital Partners GP
Sr One Capital Management
MPM Oncology Impact Management
Omega Fund Management

View all funds holding Engene Holdings